Post Uterine Cancer Treatment
After your treatment is finished and you enter Survivorship, here are a few resources that will help you going forward:
- SHARE’s Webinar : Moving Forward After Uterine Cancer Treatment: Surveillance Strategies, Testing, and Watching for Recurrence
- An article on “Living as an Endometrial Cancer Survivor”
- Worksheet form
- Cancer Survivorship Checklist from National Coalition for Cancer Survivorship (NCCS)
- Endometrial Cancer Survivorship Plan from the Society of Gynecologic Oncology (SGO)
SHARE is here to support you at every point of your survivorship journey. You can join us for one of our support groups or call our Uterine Cancer Support Line at 844-582-6005.
Find the support you need
Support line
Reach out to our support line for compassionate support and information tailored to those affected by uterine cancer.
Patient Navigation
Access the best uterine cancer care and treatments with the help of our expert patient navigators.
Support Groups
Participate in our uterine cancer support groups to receive emotional support and practical insights from those in a similar situation.
Clinical Trials
Know your options for treatments in development.
Live Webinars
Learn directly from uterine cancer experts about the latest research developments, treatment strategies, and caregiving.
Caregivers
Navigate your way as a cancer caregiver.
Video Library
Watch our previous webinars on the latest research and insights on endometrial and uterine cancer.
Where can I get more information about metastatic breast cancer?
Call SHARE’s Metastatic Breast Cancer Helpline. Our breast cancer helpline has trained metastatic peers ranging in age from early thirties to eighty. Some have been living with metastatic disease for many years. We can answer your questions, help you figure out your options, and give you realistic hope and support. Call us at 844-ASK-SHARE (844-275-7427).
Our bi-monthly e-newsletter provides information for women living with metastatic breast cancer.
SHARE's metastatic work is sponsored in part by the following:
